Conventional wisdom holds that PD-1 binding to its ligands PD-L1/PD-L2 – expressed on myeloid cells, DCs, stromal cells, and tumor cells – provides inhibitory signals to T-cells (74). This evidence concerns the gene CD274 and neoplasm.